183 related articles for article (PubMed ID: 27183177)
1. Critical Review: Review of the Efficacy, Safety, and Pharmacokinetics of Raltegravir in Pregnancy.
Maliakkal A; Walmsley S; Tseng A
J Acquir Immune Defic Syndr; 2016 Jun; 72(2):153-61. PubMed ID: 27183177
[TBL] [Abstract][Full Text] [Related]
2. Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial.
João EC; Morrison RL; Shapiro DE; Chakhtoura N; Gouvèa MIS; de Lourdes B Teixeira M; Fuller TL; Mmbaga BT; Ngocho JS; Njau BN; Violari A; Mathiba R; Essack Z; Pilotto JHS; Moreira LF; Rolon MJ; Cahn P; Prommas S; Cressey TR; Chokephaibulkit K; Werarak P; Laimon L; Hennessy R; Frenkel LM; Anthony P; Best BM; Siberry GK; Mirochnick M
Lancet HIV; 2020 May; 7(5):e322-e331. PubMed ID: 32386720
[TBL] [Abstract][Full Text] [Related]
3. [Use of raltegravir in pregnant HIV-1 infected women: experience in different clinical scenarios].
Cecchini D; Martinez M; Morganti L; Rodriguez C
Enferm Infecc Microbiol Clin; 2014 Nov; 32(9):616-8. PubMed ID: 24556267
[No Abstract] [Full Text] [Related]
4. Raltegravir in HIV-1-Infected Pregnant Women: Pharmacokinetics, Safety, and Efficacy.
Blonk MI; Colbers AP; Hidalgo-Tenorio C; Kabeya K; Weizsäcker K; Haberl AE; Moltó J; Hawkins DA; van der Ende ME; Gingelmaier A; Taylor GP; Ivanovic J; Giaquinto C; Burger DM; ;
Clin Infect Dis; 2015 Sep; 61(5):809-16. PubMed ID: 25944344
[TBL] [Abstract][Full Text] [Related]
5. Raltegravir Plus Nevirapine as Maintenance Antiretroviral Therapy in HIV-Positive Patients: Safety, Efficacy and Pharmacokinetics.
Calcagno A; Montrucchio C; Capetti A; Guaraldi G; Cenderello G; Calza L; Lanzafame M; Marinaro L; Tettoni MC; Trentini L; D'Avolio A; Di Perri G; Bonora S
Curr HIV Res; 2016; 14(1):54-60. PubMed ID: 26415700
[TBL] [Abstract][Full Text] [Related]
6. A population pharmacokinetics analysis assessing the exposure of raltegravir once-daily 1200 mg in pregnant women living with HIV.
Bukkems VE; Post TM; Colbers AP; Burger DM; Svensson EM
CPT Pharmacometrics Syst Pharmacol; 2021 Feb; 10(2):161-172. PubMed ID: 33369217
[TBL] [Abstract][Full Text] [Related]
7. Use of raltegravir in a late presenter HIV-1 woman in advanced gestational age: case report and literature review.
De Hoffer L; Di Biagio A; Bruzzone B; Sticchi L; Prinapori R; Gerbaldo D; Gotta C; Viscoli C
J Chemother; 2013 Jun; 25(3):181-3. PubMed ID: 23783144
[TBL] [Abstract][Full Text] [Related]
8. Raltegravir versus lopinavir/ritonavir for treatment of HIV-infected late-presenting pregnant women.
Brites C; Nóbrega I; Luz E; Travassos AG; Lorenzo C; Netto EM
HIV Clin Trials; 2018 Jun; 19(3):94-100. PubMed ID: 29629852
[TBL] [Abstract][Full Text] [Related]
9. Rapid reduction in HIV viral load in late pregnancy with raltegravir: a case report.
Cha A; Shaikh R; Williams S; Berkowitz LL
J Int Assoc Provid AIDS Care; 2013; 12(5):312-4. PubMed ID: 23695227
[TBL] [Abstract][Full Text] [Related]
10. Short communication: Use of raltegravir in late-presenting HIV-infected pregnant women.
Nóbrega I; Travassos AG; Haguihara T; Amorim F; Brites C
AIDS Res Hum Retroviruses; 2013 Nov; 29(11):1451-4. PubMed ID: 23731224
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of HIV-Integrase Inhibitors During Pregnancy: Mechanisms, Clinical Implications and Knowledge Gaps.
van der Galiën R; Ter Heine R; Greupink R; Schalkwijk SJ; van Herwaarden AE; Colbers A; Burger DM
Clin Pharmacokinet; 2019 Mar; 58(3):309-323. PubMed ID: 29915921
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of abacavir/lamivudine with raltegravir in treatment-experienced and treatment-naïve patients with HIV-1 infection: an observational, retrospective, multi-centre study.
Rizzardo S; Lanzafame M; Lattuada E; Bragantini D; Nicolè S; Calza L; Tacconelli E
Int J STD AIDS; 2019 Apr; 30(5):467-471. PubMed ID: 30999834
[TBL] [Abstract][Full Text] [Related]
13. Long-term tolerability and effectiveness of raltegravir in Japanese patients: Results from post-marketing surveillance.
Kuroishi N; Watananbe A; Sakuma R; Ruzicka DJ; Hara M
PLoS One; 2019; 14(1):e0210384. PubMed ID: 30625208
[TBL] [Abstract][Full Text] [Related]
14. Protecting the fetus against HIV infection: a systematic review of placental transfer of antiretrovirals.
McCormack SA; Best BM
Clin Pharmacokinet; 2014 Nov; 53(11):989-1004. PubMed ID: 25223699
[TBL] [Abstract][Full Text] [Related]
15. [Antiretroviral therapy containing raltegravir in HIV-infected pregnant women: Systematic review].
García-Fernández L; Fiestas F; Vásquez R; Benites C
Rev Chilena Infectol; 2016 Oct; 33(Suppl 1):60-66. PubMed ID: 28453028
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy at 240 weeks of different raltegravir formulations in children with HIV-1: a phase 1/2 open label, non-randomised, multicentre trial.
Nachman S; Alvero C; Teppler H; Homony B; Rodgers AJ; Graham BL; Fenton T; Frenkel LM; Browning RS; Hazra R; Wiznia AA;
Lancet HIV; 2018 Dec; 5(12):e715-e722. PubMed ID: 30527329
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of raltegravir-containing regimens in antiretroviral-naïve and -experienced individuals in routine clinical practice.
Jaeckle M; Khaykin P; Haberl A; De Leuw P; Schüttfort G; Stephan C; Wolf T
Int J STD AIDS; 2016 Nov; 27(13):1170-1179. PubMed ID: 26429890
[TBL] [Abstract][Full Text] [Related]
18. Brief Report: Vaginal Viral Shedding With Undetectable Plasma HIV Viral Load in Pregnant Women Receiving 2 Different Antiretroviral Regimens: A Randomized Clinical Trial.
Frenkel LM; Morrison RL; Fuller TL; Gouvêa MI; Benamor Teixeira ML; Coombs RW; Shapiro DE; Mirochnick M; Hennessey R; Whitson K; Chakhtoura N; João EC
J Acquir Immune Defic Syndr; 2021 Dec; 88(4):361-365. PubMed ID: 34369908
[TBL] [Abstract][Full Text] [Related]
19. Substitution of nevirapine or raltegravir for protease inhibitor vs. rosuvastatin treatment for the management of dyslipidaemia in HIV-infected patients on stable antiretroviral therapy (Nevrast study).
Calza L; Magistrelli E; Colangeli V; Borderi M; Bussini L; Bon I; Re MC; Viale P
Infect Dis (Lond); 2017 Oct; 49(10):737-747. PubMed ID: 28683645
[TBL] [Abstract][Full Text] [Related]
20. Impact of antiretroviral regimen on viral suppression among pregnant women living with HIV in Brazil.
Pascom ARP; Fonseca FF; Pinho RGG; Perini FB; Pereira G; Avelino-Silva VI
Int J STD AIDS; 2020 Aug; 31(9):903-910. PubMed ID: 32702281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
